Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a pharmaceutical company focused on transforming medicines that can transform lives. We operate a business model that focuses on the following: · developing innovative products that address unmet medical needs in the marketplace; · obtaining patents for those innovative ideas which we believe have value in the marketplace; · utilizing a small group of talented employees to develop those ideas by working with strategic outsource partners; · developing a regulatory pathway with the appropriate agency; and · determining how best to commercialize our products. We hire experts with strong project management skills in the specific disciplines we believe are important to maintain within our Company. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.84 |
| Quarterly EPS Est: | -0.22 |
| PEG Ratio: | -1.62 |
|
Mean Recommendation: View Summary / View All |
1.6 |
Data is provided by Zacks Investment Research

